Guidelines & Reports
Consensus Statement: Ultrasonography of superficial soft-tissue masses.
25 Apr, 2022 | 00:36h | UTC
WHO recommends highly successful COVID-19 therapy (nirmatrelvir-ritonavir) and calls for wide geographical distribution and transparency from originator.
22 Apr, 2022 | 09:36h | UTCSee also:
A living WHO guideline on drugs for covid-19 – The BMJ
Therapeutics and COVID-19: living guideline – World Health Organization
Related:
Commentary on Twitter
🔥 Our latest @WHO living guidance on drugs for #COVID19, with new recommendations for nirmatrelvir-ritonavir & updated recommendation for remdesivir in non-severe illness.@bmj_latest: https://t.co/KuJjwzeTPV@WHO: https://t.co/n3iQx3pdmY
@theMAGICapp: https://t.co/dA7YYzeAZ1 pic.twitter.com/LvAhJf70UY
— Arnav Agarwal (@ArnavAgarwalMD) April 21, 2022
[News release – not published yet] New guidelines from WHO recommend a simpler, safer treatment for cryptococcal disease in people living with HIV.
21 Apr, 2022 | 10:28h | UTCRelated Study: Single-Dose Liposomal Amphotericin B Treatment for Cryptococcal Meningitis – New England Journal of Medicine (link to abstract – $ for full-text)
SCAI Position Statement on best practices for percutaneous axillary arterial access and training.
21 Apr, 2022 | 10:02h | UTCCommentary: Percutaneous Axillary Access: SCAI Calls for Best Practices – TCTMD
Commentary on Twitter
@SCAI releases new document on "Best Practices on Percutaneous Transaxillary Arterial Access and Training."https://t.co/TFsK84nFMe pic.twitter.com/7jNSeuSdEF
— MyJSCAI (@MyJSCAI) April 19, 2022
USPSTF Draft Statement: Postmenopausal women should not use hormone therapy to prevent chronic health problems.
20 Apr, 2022 | 10:15h | UTCDraft Recommendation Statement: Hormone Therapy for the Primary Prevention of Chronic Conditions in Postmenopausal Persons – U.S. Preventive Services Task Force
Commentary: USPSTF Advises Against Hormone Therapy to Prevent Chronic Conditions – HealthDay
British Guideline for the treatment of chronic lymphocytic leukemia.
21 Apr, 2022 | 10:00h | UTCGuideline for the treatment of chronic lymphocytic leukaemia – British Journal of Haematology
Expert Guidance: Strategies to prevent central line-associated bloodstream infections in acute-care hospitals.
20 Apr, 2022 | 10:13h | UTC
Commentary on Twitter
Prevention of central line-associated bloodstream infections in acute-care hospitals- 2022 updatehttps://t.co/o3AReYvJIu pic.twitter.com/QsgYYezhqj
— K Pavithran (@drkpavithran) April 19, 2022
Article under a http://creativecommons.org/licenses/by/4.0/ license
German guidelines for the diagnosis and treatment of varicose veins.
20 Apr, 2022 | 09:49h | UTCS2k guidelines: diagnosis and treatment of varicose veins – Leitlinien und Empfehlungen
ASCO Guideline Update: biomarkers for adjuvant endocrine and chemotherapy in early-stage breast cancer.
20 Apr, 2022 | 09:47h | UTC
AAOS Guideline: Prevention of surgical site infections after major extremity trauma.
19 Apr, 2022 | 02:35h | UTCEvidence Review: Prevention of Surgical Site Infection After Extremity Trauma (2022)
AHA Scientific Statement: Management of hypertension in patients with ventricular assist devices.
19 Apr, 2022 | 02:09h | UTC
AHA Scientific Statement: Nonalcoholic fatty liver disease and cardiovascular risk.
18 Apr, 2022 | 10:37h | UTCNews Releases:
Fatty liver disease not caused by alcohol is common – and often missed – American Heart Association
Guidelines for therapeutic drug monitoring of vancomycin in the framework of model-informed precision dosing.
18 Apr, 2022 | 10:26h | UTCRelated Guideline:
Commentary on Twitter
https://twitter.com/IDPharmacometrx/status/1514219239732912131
USPSTF draft statement recommends screening for anxiety and depression in children and adolescents ages 8 to 18 years.
13 Apr, 2022 | 11:05h | UTCDraft Statements:
Screening for Anxiety in Children and Adolescents – US Preventive Services Task Force
Commentary:
USPSTF Recommends Anxiety, Depression Screening for Children – HealthDay
Evidence- and consensus-based guidelines for drug-drug interactions with anticancer drugs; A practical and universal tool for management.
12 Apr, 2022 | 10:02h | UTC
AHA Scientific Statement: SARS-CoV-2 infection and associated cardiovascular manifestations and complications in children and young adults.
12 Apr, 2022 | 09:59h | UTCNews Release: Heart issues after COVID-19 uncommon in children and young adults, more research needed – American Heart Association
Commentary: COVID-19 CV Complications in Children Are Rare, Treatable: AHA Statement – TCTMD
Acute phase of Kawasaki disease: a review of national guideline recommendations.
12 Apr, 2022 | 08:32h | UTC
Clinical update on COVID-19 for the emergency and critical care clinician: Medical management.
11 Apr, 2022 | 02:00h | UTC
Keep the size of your waist to less than half of your height, updated NICE draft guideline recommends.
11 Apr, 2022 | 02:01h | UTCCommentaries:
Keep your waist to less than half your height, guidance says – BBC
Draft Guideline: Obesity: identification and classification of overweight and obesity – National Institute for Health and Care Excellence
UK clinical guideline for the prevention and treatment of osteoporosis.
11 Apr, 2022 | 01:33h | UTCUK clinical guideline for the prevention and treatment of osteoporosis – Archives of Osteoporosis
Guideline Synopsis: Management of chronic multisymptom illness.
11 Apr, 2022 | 01:29h | UTC
NCCN Guidelines: CAR T-cell–related toxicities in patients with cancer.
11 Apr, 2022 | 01:32h | UTCRelated:
Reviews: CAR T-Cell Therapy Toxicities and Side Effects
Reviews: CAR T-Cell Therapy Toxicities and Side Effects
Critical Care Management of Chimeric Antigen Receptor T Cell–related Toxicity. Be Aware and Prepared
Reviews: CAR T-Cell Therapy Toxicities and Side Effects
Long COVID in children: a modified Delphi process.
8 Apr, 2022 | 10:40h | UTCRelated:
First research definition for ‘Long COVID’ in kids and young people formally agreed.
Editorial | Long covid in children and adolescents – “Risk appears low, but many questions remain”.
Review: Long COVID symptoms in children rarely persist beyond three months.
WHO Strategic framework for collaboration on antimicrobial resistance.
7 Apr, 2022 | 08:41h | UTCStrategic framework for collaboration on antimicrobial resistance – World Health Organization
Related:
Four priority actions to slow the silent pandemic of antimicrobial resistance.
Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis.
Commentary on Twitter
#DYK: Drug resistant organisms are found in people, animals, food, plants and the environment.
That's why WHO works in collaboration with @FAO, @OIEAnimalHealth & @UNEP to address #AntimicrobialResistance https://t.co/enhUb1jg2g pic.twitter.com/9elCBspx4y— World Health Organization (WHO) (@WHO) April 6, 2022
Recommendations for reporting results of diagnostic genomic testing.
7 Apr, 2022 | 08:02h | UTC


